a public good project by the
Synthesis
Company
of California

© 2026

Craig W. Lindsley | doi.page

0 works0 citations0 h-index

Craig W. Lindsley

Vanderbilt University(US)Drug Discovery Laboratory (Norway)(NO)Health Advances (United States)(US)Center for Discovery(US)Vanderbilt University Medical Center(US)

Publications by Year

Research Areas

Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Academic Writing and Publishing, Ion channel regulation and function, Chemical Synthesis and Analysis

Most-Cited Works

→ Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders(2008)1,036 cited
→ Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors(2004)499 cited
→ The Akt/PKB pathway: molecular target for cancer drug discovery(2005)493 cited
→ M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.(2015)437 cited
→ Efficient Synthesis of Imidazoles from Aldehydes and 1,2-Diketones Using Microwave Irradiation(2004)425 cited
→ Phospholipase D: Enzymology, Functionality, and Chemical Modulation(2011)377 cited

→ In Vivo Structure−Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP Inhibitors(2009)

376 cited

→ Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia(2008)325 cited

→ A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models(2005)299 cited

→ Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders(2009)284 cited